CVRx, Inc. (CVRX) Social Stream
CVRx Inc (CVRX) Price Targets From Analysts
Use the tables below to see what analysts covering CVRx Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-01 | 4 | $30 | $24 | $26.666 | $6.29 | 323.94% |
| 2022-02-15 | 4 | $30 | $20 | $24.666 | $6.29 | 292.15% |
CVRX reports an average of 84.39% for its upside potential over the past 26 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-19 | NA | 30 | 24 | 26.670 | 18.02 | 48% |
| 2021-09-10 | NA | 30 | 24 | 26.670 | 18.82 | 41.71% |
| 2021-09-13 | NA | 30 | 24 | 26.670 | 18.29 | 45.82% |
| 2022-02-01 | 4 | 30 | 24 | 26.666 | 8.14 | 227.59% |
| 2022-02-15 | 4 | 30 | 20 | 24.666 | 8.62 | 186.15% |
CVRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, CVRx Inc's upside potential (average analyst target price relative to current price) is higher than 185.18% of them.
- CVRX has a higher number of analysts covering the stock than 38.16% of all US stocks.
- CVRx Inc's variance in analysts' estimates is lower than 37.78% of Healthcare stocks.
- CVRX has a higher average analyst price target than 68.68% of Medical Equipment stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to CVRx Inc are CTSO, CSII, and CODX.
What is the outlook for CVRX? Use POWR Ratings for clearer insight into price direction.